Ducommun (DCO) Following Guggenheim Coverage Is The Valuation Story Getting Stronger

Renewed coverage puts Ducommun in focus

Fresh coverage of Ducommun (DCO) by Guggenheim Securities, framed around aerospace manufacturing tailwinds and ongoing demand from defense missile programs, has put the US$2.6b aerospace supplier back on investors' radar.

At a share price of US$170.56, Ducommun has cooled slightly in the past week and month, yet the stock still carries strong momentum with a year to date share price return of 76.2% and a 3 year total shareholder return of 268.7%. Guggenheim’s renewed coverage now gives those moves a fresh narrative anchor around aerospace and defense demand.

Capitalize on the renewed focus on Ducommun by scanning a curated set of aerospace and defense manufacturers through 31 resilient stocks with low risk scores.

After a 76.2% year to date run, Ducommun now trades at US$170.56, while analyst and intrinsic estimates cluster well above that level. So where does a reasonable fair value line actually fall in that gap?

Most Popular Narrative: 20% Undervalued

Ducommun’s most followed valuation narrative pegs fair value at $212 per share, comfortably above the last close at $170.56. This puts the recent pullback into context and frames Guggenheim’s renewed attention against a longer running earnings story.

Ongoing mix shift toward higher margin engineered products and aftermarket, with engineered products rising from 9% of revenue in 2017 to 23% over the past 12 months and management aiming for roughly 25% by 2027 and 40% with 20% aftermarket by 2032, supports the view that Ducommun can continue to lift gross margin and adjusted EBITDA margin from the current 17.1% level.

See why 13 investors see Ducommun as 20% undervalued.

Result: Fair Value of $212 (UNDERVALUED)

Still, the thesis around Ducommun can wobble if internal control issues resurface or if the recent backlog decline and margin pressure persist longer than expected.

Find out about the key risks to this Ducommun narrative.

Next Steps

If the mix of optimism and caution around Ducommun leaves you undecided, act promptly, review the underlying data, and weigh the 3 key rewards.

Looking for more ideas beyond Ducommun?

If Ducommun has your attention, do not stop here. Broaden your radar and pressure test your thesis against other opportunities that match your risk and return preferences.

• Target potential mispricing by scanning a curated pool of quality candidates through 30 high quality undervalued stocks.
• Strengthen your downside protection and focus on financial resilience using the list of solid balance sheet and fundamentals (25 results).
• Hunt for overlooked potential and compare Ducommun against a 20 high quality undiscovered gems before capital moves there without you.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com